The use of atypical antipsychotics in the management of schizophrenia
- 1 January 1999
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 47 (1), 13-22
- https://doi.org/10.1046/j.1365-2125.1999.00849.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trialsJournal of Psychopharmacology, 1997
- Education for educating surgeonsBMJ, 1996
- SchizophreniaNew England Journal of Medicine, 1996
- Change in neuroleptic prescribing practicePsychiatric Bulletin, 1995
- Risperidone-induced neuroleptic malignant syndromeThe Lancet, 1994
- Invisible schizophrenia: A postal survey of the incidence and management of new cases of schizophrenia in primary careJournal of Mental Health, 1994
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United StatesNew England Journal of Medicine, 1993
- Schizophrenia: developmental neuroscience and pathobiologyThe Lancet, 1993
- Pitfalls and Problems of the Long Term Use of Neuroleptic Drugs in SchizophreniaDrug Safety, 1993
- An Update on the Epidemiology of Schizophrenia*The Canadian Journal of Psychiatry, 1990